Prognostic factors in high and intermediate grade non-Hodgkin's lymphoma.
An analysis of prognostic factors has been performed on 260 patients with high and intermediate grade non-Hodgkin's lymphoma (NHL) treated over an 11-year period between 1975 and 1986. The overall 5-year survival rate was 50% with a median follow-up of 72 months. Over 20 clinical, radiological...
Main Authors: | Cowan, R. A., Jones, M., Harris, M., Steward, W. P., Radford, J. A., Wagstaff, J., Deakin, D. P., Crowther, D. |
---|---|
Format: | Online |
Language: | English |
Published: |
Nature Publishing Group
1989
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2247014/ |
Similar Items
-
Combination chemotherapy for intermediate and high grade non-Hodgkin's lymphoma.
by: Dhaliwal, H. S., et al.
Published: (1993) -
Phase II trial of temozolomide in low-grade non-Hodgkin's lymphoma.
by: Woll, P. J., et al.
Published: (1995) -
Male fertility after VAPEC-B chemotherapy for Hodgkin's disease and non-Hodgkin's lymphoma.
by: Radford, J. A., et al.
Published: (1994) -
Chlorambucil and interferon for low grade non-Hodgkin's lymphoma.
by: Rohatiner, A. Z., et al.
Published: (1987) -
A critical analysis of prognostic factors for survival in intermediate and high grade non-Hodgkin's lymphoma. Scotland and Newcastle Lymphoma Group Therapy Working Party.
by: Hayward, R. L., et al.
Published: (1991)